CEDAR KNOLLS, N.J.--(BUSINESS WIRE)--Emisphere Technologies, Inc. (OTC BB: EMIS), a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and pharmaceutical compounds using its Eligen® Technology, today announced that President and Chief Executive Officer, Michael V. Novinski, will present a corporate overview at the 13th Annual Biotech & Specialty Pharma Investment Conference, sponsored by the New York Society of Securities Analysts, at 11:30 AM on December 1, 2009. The conference is being held at the New York Society of Security Analysts, 1177 Avenue of the Americas, New York, NY.
